• Women experiencing menopause have long weathered uncomfortable symptoms in silence.
• Advancements in menopause care include personalized hormone therapy, telehealth support, and non-hormonal therapies.
• This article is part of "Transforming Treatments," a series on medical innovations that save time, money, or discomfort.

For decades, menopause has been treated like a medical nuisance to be managed silently. Women, knowing it's taboo to talk about, have quietly dealt with symptoms like hot flashes, vaginal dryness, restless nights, brain fog, mood swings, and plummeting libido.

"We've had a two-sided problem that is being unraveled: patients who have been left to suffer and providers who have been left without education," Jessica Nazzaro, a board-certified OBGYN, certified menopause practitioner, and a medical advisor for at-home hormone tracking company Mira, told Business Insider. Patients now "know they are not alone, not crazy, and can find help."

Today, many can test their hormone levels at home, talk to menopause specialists online, and get personalized prescriptions shipped directly to their doors.

This shift marks a reimagining of how women navigate their midlife years. Once dismissed as an inevitable decline, menopause is now treated as another phase of health — one that can be supported, studied, and optimized.

Hormone therapy gets a makeover

Hormone replacement therapy (HRT) — which restores a patient's levels of estrogen, progesterone, or both to relieve menopause symptoms — was once the only solution women could turn to for things like night sweats, hot flashes, and vaginal dryness.

Then came the Women's Health Initiative (WHI) study in 2002, a long-term national study on preventing breast and colorectal cancer, heart disease, and osteoporosis in postmenopausal women, which found that HRT could increase cancer risk.

Prescriptions plummeted, and stigma spiked.

In the years after, a group of doctors and researchers revisited the study and found it to be flawed because of its narrow scope. The WHI, which looked at disease risk in postmenopausal women, did not include vaginal estrogen, for example.

Experts now tend to advocate for personalized treatment plans and say that cancer risk depends on the type of hormones used and the duration of treatment.

"We've learned that HRT is indeed protective of heart health, brain health, and bone health. It does not cause breast cancer, as was publicized by the WHI, but rather can proliferate an estrogen-sensitive tumor in the breast or other tissue," Nazzaro said.

According to Dr. Kathleen Green, an OB-GYN at Maven Clinic, "More recent studies show that for most women, the benefits of HRT far outweigh the risks."

Starting hormone therapy closer to the onset of menopause — typically before age 60 or within 10 years of entering menopause — can help alleviate symptoms and improve bone health.

The biggest change? Personalization. Doctors now consider a woman's age, symptoms, medical history, and time since menopause to determine the best form and dose of HRT — whether it's a pill, patch, gel, vaginal cream, or ring.

Tech makes menopause more manageable

As more women demand better care, tech companies are offering to meet them where they are. At-home hormone testing tools like Mira and Proov can track users' hormone levels and turn them into personalized scores and cycle insights.

According to Nazzaro, Mira's device tracks hormonal shifts with lab-level accuracy and "helps women see patterns in their own cycles, understand which stage of menopause they're in, and make informed decisions about symptom management, lifestyle adjustments, or treatments."

Dr. Sophia Yen, the CEO and cofounder of Pandia Health, is a fan of Mira and told Business Insider that it's seamless to use — you simply collect your urine in a cup — and it provides "lab-grade results," all from the comfort of your home.

Telehealth companies such as Midi, Gennev, Pandia Health, and Winona provide virtual appointments with menopause-trained clinicians — such as board-certified OB/GYNs and doctors who are also NASM-certified menopause practitioners. Pandia Health also offers asynchronous telemedicine, where women can message doctors without face or voice contact — establishing a safe space to share their concerns.

Beyond hormones: New options for symptom relief

Even with the rise of personalized HRT, some women can't or prefer not to take hormones — especially breast cancer survivors. That's driving innovation in non-hormonal therapies.

In 2025, the FDA approved Lynkuet, a gel capsule from Bayer that blocks brain receptors responsible for hot flashes. In clinical trials of more than 700 women, it cut the frequency of hot flashes within a week.

"Many cannot or will not take hormones, so Lynkuet could be a wonderful option," Alyssa Dweck, the chief medical officer at Bonafide Health, told Business Insider.

Other new options include estetrol, a natural estrogen steroid pill, which is designed to address hot flashes, vaginal atrophy, and loss of bone mass. Vaginal estrogen creams and suppositories that treat dryness, itching, and irritation can also help.

After years of debate, the FDA recently removed the "black box" warning — the FDA's highest issued safety label — from estrogen-related products. The move could make women feel more comfortable using these medications, Nazzaro said.

"I've had patients who pick up their prescription for vaginal estrogen after a thorough discussion and decide not to use it specifically because of the black box warning," Nazzaro told Business Insider.

Doctors say the shift isn't just happening among menopausal women — it's starting earlier.

"I have women in their 30s presenting to my office wanting to understand what they might anticipate when they enter perimenopause," Dweck said. They want to understand "what proactive measures can be taken to avoid distressing symptoms."

That proactive mindset, paired with more tools and data, could redefine menopause care for the next generation.

"I feel incredibly optimistic," Dweck said.

The bottom line in menopause care

Staying open-minded to emerging research and aware of the risks and benefits of new therapies is crucial to navigating this phase of life, said Dweck. She suggested being proactive and educating yourself about menopause with credible sources like The Menopause Society.

Certain lifestyle adjustments like exercise, nutrition, and sleep can also make a major difference and support treatments like hormone therapy, non-hormonal drugs, or clinically studied supplements, Dweck said.

And remember — although the menopause care market offers many products that are touted as "solutions," they may not have solid scientific evidence to support their claims.

"Product labels can be overwhelming, frightening, and confusing, and for this reason, a comprehensive discussion with an experienced healthcare provider about indications for use, risks, benefits, and specific use instructions is warranted," Dweck said.

She recommended considering personal needs based on symptoms, medical and family history, medications, and lifestyle habits. There's no one-size-fits-all approach or experience when it comes to menopause.

• The deadline is approaching for prosecutors to file fraud chagres related to $43 billion in pandemic aid spending.
• Senator Joni Ernst says her Democratic counterpart is blocking a bill to give them five more years.
• Watchdogs previously flagged the Shuttered Venue Operators Grant and a restaurant bailout fund.

The top Republican on the Senate Small Business Committee said Democrats are blocking a measure to give federal prosecutors more time to investigate bailouts for restaurants and the live-entertainment industry.

Senator Joni Ernst said Senator Ed Markey is holding up her bill that would give investigators until at least 2031 to file charges for defrauding the $28.6 billion Restaurant Revitalization Fund or the $14.5 billion Shuttered Venue Operators Grant program.

"We are not getting a lot of cooperation coming from our Ranking Member, Markey, and the Senate Democrats," Ernst told Business Insider. "I'm not very optimistic that it's going to happen, and it's very, very frustrating."

Markey's office declined to respond to a request for comment.

Less than two weeks remain for the Senate to pass the legislation, which would enable the bill to move to the president's desk and possibly be signed into law.

It's not clear whether Ernst has formally sought unanimous consent to pass the statute-of-limitations extender bill because the process can take place informally, off the Senate floor. It's possible the measure could be passed next year, though the deadline to prosecute some SVOG fraud cases could lapse as soon as April 8.

Business Insider documented how over $200 million from the SVOG program went to celebrities who used taxpayer money for private jets, lavish parties, luxury clothes, and other questionable spending.

Investigators haven't accused any of those recipients of wrongdoing, and most of the grants discussed in BI's stories were closed out by the Small Business Administration.

Mike Galdo, a former prosecutor who focused on pandemic fraud, said the bill could give agents, analysts, and prosecutors more time to build cases.

"Given some of the ambiguity in the language in the SVOG statute and regulations, as well as enforcement priorities other than fraud taking center stage for this Administration, it is unclear how many additional SVOG-related enforcement matters will be brought," he said in an email.

Ernst said Democrats preferred to "rant and rail" against President Donald Trump. At a committee hearing for SBA matters on December 10, Markey accused Republicans of waging "an all-out assault" on an SBA program that sets aside billions of dollars in federal contracts for small businesses owned by women and racial and ethnic minorities.

Christmas crunch time in Congress

A similar bill to extend the statute of limitations for the SVOG program and the restaurant fund has already passed the House of Representatives with bipartisan support.

Both Ernst and Markey have pointed fingers across the aisle for delaying their legislative priorities. Ernst yesterday sought unanimous consent to pass a bill that would have clawed back more than $65 billion in unspent COVID relief funds, a measure that was blocked by Senator Ron Wyden, an Oregon Democrat. And Markey blamed Republicans for blocking a one-year extension of two programs that dole out billions in grants to tech-oriented small businesses.

Representative Gil Cisneros, a Democratic congressman from California, said earlier this month that the SBA's inspector-general has 31 open Restaurant Revitalization Fund cases and six open Shuttered Venue Operators Grant cases.

A spokesman for the SBA's inspector-general's office didn't respond to a request for comment about those numbers.

The two programs cut checks of up to $10 million meant to support businesses that had been hard-hit by the COVID-19 pandemic in 2020 and 2021, as waves of the deadly virus and government stay-at-home orders led businesses dependent on in-person gatherings to struggle.

Government auditors faulted the SBA over its internal controls, and the combined total of fraud and waste in those and other pandemic programs may exceed $400 billion. Prosecutions have barely scratched the surface compared to the scale of the suspected fraud, but some misspent money could also be recovered through administrative actions or civil lawsuits.

When you buy through our links, Business Insider may earn an affiliate commission. Learn more

Linkin Park’s From Zero World Tour continues with a global slate of shows extending into 2026, supporting the band's long‑awaited 8th studio album From Zero. The tour was officially announced on September 5, 2024, when Linkin Park revealed their comeback, introduced new co-lead vocalist Emily Armstrong of Dead Sara and new drummer Colin Brittain, and shared the lead single, "The Emptiness Machine."

This marks Linkin Park's first full world tour in seven years and their first without former front man Chester Bennington, who tragically died in 2017.

If you’re looking to catch a piece of the action and see Linkin Park live this year, we’ve got you covered. Here’s our breakdown for how to get tickets for Linkin Park’s 2025 From Zero World Tour, as well as their festival appearances. This will include information on Linkin Park’s tour schedule, purchasing details, and price comparisons between tickets. You can also look at ticket details at your leisure on StubHub and Vivid Seats.

• See also: Is StubHub legit? | Bon Jovi tickets | AC/DC tickets | Iron Maiden tickets | No Doubt tickets | The Strokes tickets | Yungblud tickets

Linkin Park’s 2025 tour schedule

Linkin Park’s From Zero World Tour spans multiple continents with dates scheduled well into 2026. The global trek follows the band's 2024 reunion and live return, with shows across North America, Europe, Asia, and Latin America. In 2026, the tour continues with international stops including the Middle East, India, Australia, and a European leg that runs through stadiums and festivals in Sweden, Germany, Austria, Spain, Italy, and Switzerland through late June. The run also includes high-profile festival appearances, such as Download Festival and Rock in Rio Lisboa, providing fans around the world with numerous opportunities to see Linkin Park live.

International

* Indicates a music festival Linkin Park will be performing at, in addition to several other artists.

• Follow our Instagram page and WhatsApp channel for more deals and buying guides.

  ---

How to buy tickets for Linkin Park’s 2025 concert tour

Original tickets for Linkin Park’s From Zero World Tour are available for purchase on Ticketmaster. Tickets can also be purchased from verified resale vendors such as StubHub and Vivid Seats. As the demand for each show varies by location and performance date, you may find better options from resale vendors if you are looking for a specific seating location or are interested in attending a high-demand event.

How much are Linkin Park tickets?

Ticket prices for Linkin Park’s From Zero World Tour in 2025 and 2026 vary widely depending on the city, venue, and whether tickets are purchased through official sources or secondary marketplaces. Official tickets for tour stops are available through Ticketmaster, as long as they are still in stock. General-admission and standard seats start at different price points, based on demand and location. Verified resale platforms, such as StubHub and Vivid Seats, also list tickets, often at higher prices due to limited availability and market demand.

On resale marketplaces, the lowest secondary-market prices typically appear for less-in-demand international stops, while larger US and European shows command higher rates. For example, resale listings on StubHub show some 2025 dates with lower prices compared to high-demand stops later in the tour, and Vivid Seats currently shows resale prices starting around the mid-hundreds for select 2026 European dates.

In addition to standard tickets, many Linkin Park tour stops offer VIP packages through Ticketmaster and partner sites. These may include perks such as early entry, exclusive merchandise, premium seating, and VIP-only experiences. Popular VIP tiers for the From Zero World Tour have ranged from mid-hundreds to higher-end pricing, depending on inclusions and venue, and actual costs can vary by market and availability. Always check the specific event page on Ticketmaster for the most accurate pricing and VIP options before buying, as packages can sell out quickly.

Who is opening for Linkin Park’s tour?

Linkin Park’s From Zero World Tour has announced several opening acts for select performances, including Queens of the Stone Age, Spiritbox, AFI, Architects, Grandson, Jean Dawson, JEPG Mafia, and Pvris.

Will there be international tour dates?

There are currently 22 international Linkin Park tour dates scheduled, including festival appearances and tour stops on the From Zero World Tour. These dates span South America and Europe, extending through June 2026. Additionally, Linkin Park is scheduled to make a stop in Vancouver, Canada, on September 21, 2025.

Who is the new Linkin Park singer?

Linkin Park announced on September 5, 2024, during a livestreamed concert, that Emily Armstrong would join Linkin Park as a co-vocalist, replacing Chester Bennington, who tragically died in 2019. Emily Armstrong, previously the lead vocalist of the group Dead Sara, began collaborating with Linkin Park in 2019 during their six-year hiatus. Armstrong has been praised for her vocal abilities, which complement the established sound of Linkin Park. The group released “From Zero”, their first album with Armstrong as vocalist, on November 15, 2024.

• OpenAI said GPT-5.2, its latest model, is its best yet at doing "professional knowledge work."
• In a benchmark test, OpenAI said it outperformed industry professionals in tasks across 44 occupations.
• GPT-5.2's release comes just days after OpenAI CEO Sam Altman declared a "code red" in response to Google's Gemini 3.

OpenAI released its anticipated update to GPT-5 on Thursday, boasting that the new AI is "the most capable model series yet for professional knowledge work."

"We designed GPT‑5.2 to unlock even more economic value for people; it's better at creating spreadsheets, building presentations, writing code, perceiving images, understanding long contexts, using tools, and handling complex, multi-step project," the company said in a statement.

In a benchmark test called GDPval, OpenAI said its new AI model can outperform "industry professionals at well-specified knowledge work tasks spanning 44 occupations."

"GPT‑5.2 Thinking produced outputs for GDPval tasks at >11x the speed and <1% the cost of expert professionals, suggesting that when paired with human oversight, GPT‑5.2 can help with professional work," the company said.

And in a note that is sure to catch the attention of bankers, OpenAI wrote that in an internal benchmark of junior investment banking analyst spreadsheet modeling tasks — "such as putting together a three-statement model for a Fortune 500 company with proper formatting and citations, or building a leveraged buyout model for a take-private" — the new model's score per task was "9.3% higher than GPT‑5.1's, rising from 59.1% to 68.4%" on average.

The company also touted its gains in agentic coding ability.

The release comes just over a week after OpenAI CEO Sam Altman declared a "code red" in a private message to employees, marshaling more resources to ChatGPT amid increasing competition from Google and other companies.

Google has been considered by many in tech to be gaining, if not surpassing, OpenAI in the AI race with its recent release of Gemini 3 AI model.

This is a developing story…

• Ahead of the premiere of her Eras Tour docuseries, Taylor Swift appeared on "The Late Show."
• Swift said she values career longevity and admires artists who can "keep a good thing going."
• Swift said she's aware that some people would prefer her to "go away," but she doesn't want to.

Taylor Swift has been known to accept feedback from fans and critics, but there's one request she refuses to heed: "Go away."

Ahead of the premiere of her Disney+ docuseries, "The End of an Era," Swift appeared on "The Late Show with Stephen Colbert" to discuss her recent achievements and milestones.

When Colbert asked Swift who she could turn to for advice, she listed rock star Stevie Nicks and pop producer Max Martin as confidants.

"What I look up to the most in people is career longevity — career longevity, friendship longevity, longevity in their relationships, you know? How do you keep a good thing going?" Swift said.

"I think there are certain corners of our society that really love that and look up to longevity," she continued. "There are also corners that are like, 'Give someone else a turn! Can't you just go away so we can talk about how good you were?' And I'm like, 'I don't want to.'"

Swift has faced accusations of overexposure throughout her career, but particularly in the last few years. Her cross-continental, 149-show Eras Tour, which concluded in December 2024, garnered extensive media coverage and consistently went viral on social media. The New Yorker said Swift had achieved "complete domination over popular culture."

When Swift released "The Tortured Poets Department" halfway through the tour's two-year run, fans and critics alike called the album overlong and overindulgent. When it topped the Billboard 200 for 17 weeks, fans of other artists complained that Swift was sabotaging her fellow pop stars, including Billie Eilish and Charli XCX, by preventing their albums from reaching No. 1 on the chart.

Swift's newest album, "The Life of a Showgirl," was met with similar reproach. In his review for The Atlantic, Spencer Kornhaber wrote, "'Showgirl' is the sound of an overworked and overexposed entertainer reaching the mountaintop to find something worse than disappointment: burnout." Swift's prolificacy and sales tactics have been described as shameless and excessive.

Still, Swift has refused to shrink away from the spotlight. The first two episodes of "The End of an Era" will be available to stream on Friday, along with an extended version of her Eras Tour concert movie, featuring a new segment with songs from "The Tortured Poets Department." The remaining four episodes of the docuseries will be released in pairs over the next two weeks.

During her interview with Colbert, Swift also joked that she prefers to think of herself as "passionate" and "hyperactive," rather than a workaholic.

"When I take time off, it's always just like, I can't slow down the fact that I need to get up and do a lot of things today. But I can change what those things are," she said. "I can figure out how to chill out, but I'm never gonna be a chill person."